APA (7th ed.) Citation

Seyler, C., Li, J., Schweizer, P. A., Katus, H., & Thomas, D. (2014). Inhibition of cardiac two-pore-domain KSUP+/SUP (KSUB2P/SUB) channels by the antiarrhythmic drug vernakalant: Comparison with flecainide. European journal of pharmacology, 724, . https://doi.org/10.1016/j.ejphar.2013.12.030

Chicago Style (17th ed.) Citation

Seyler, Claudia, Jin Li, Patrick Alexander Schweizer, Hugo Katus, and Dierk Thomas. "Inhibition of Cardiac Two-pore-domain KSUP+/SUP (KSUB2P/SUB) Channels by the Antiarrhythmic Drug Vernakalant: Comparison with Flecainide." European Journal of Pharmacology 724 (2014). https://doi.org/10.1016/j.ejphar.2013.12.030.

MLA (9th ed.) Citation

Seyler, Claudia, et al. "Inhibition of Cardiac Two-pore-domain KSUP+/SUP (KSUB2P/SUB) Channels by the Antiarrhythmic Drug Vernakalant: Comparison with Flecainide." European Journal of Pharmacology, vol. 724, 2014, https://doi.org/10.1016/j.ejphar.2013.12.030.